VeroPharma Group exists for one reason. International manufacturers lose time entering Thailand, and most of it is lost before a dossier is ever filed. We are the senior, bicultural team that closes that gap and stays accountable to the outcome.
Foreign companies routinely lose 12 months or more entering the Thai market. The wrong license, the wrong import structure, a dossier returned for rework: each misstep costs time and budget already committed, and most of them happen before Thai FDA ever opens the file.
The root cause is rarely the regulation itself. It is communication. International teams expect direct answers and clear status. That is not always how a complex, multi-party regulatory process moves locally, and the gap surfaces late, after commercial decisions have already been made against a timeline no one in Thailand actually confirmed.
VeroPharma Group was built to remove that gap. We bring senior Thai and Western regulatory specialists onto the same engagement, working the regulation and the relationships side by side, so the manufacturer always knows where the registration truly stands.
We cannot promise you the regulation will be simple. We can promise how we will carry it. These are the commitments every engagement is held to.
The specialists who scope your registration are the specialists who do it. Strategy is not set by one team and then handed down to a junior desk to execute. The judgment you buy at the start is the judgment that stays on the file.
We are measured by an approved marketing authorization, not by activity. The people who tell you a pathway is sound are the people answerable for seeing it reach the end of that pathway.
Local regulatory knowledge and Western directness on the same team. We read Thai FDA correspondence in the register it is written in, and we report it back to you in the register you work in, without anything lost between the two.
When a timeline is unrealistic, a classification is wrong, or a pathway will not hold, you hear it from us early, while it still costs nothing to change course. We do not translate a process into what a client wants to hear.
Our work is done by senior Thai regulatory professionals and Western specialists with decades of multinational pharmaceutical experience between them. They have prepared dossiers, managed Thai FDA correspondence, and structured local holder relationships across many product types and many submissions.
Our clients are typically not new to drug registration. They are new to Thailand. Our role is to make the Thai regulatory system legible to a team that already understands what registration means, without adding a layer of opacity in the process.
For work that sits beyond a current engagement, we are candid about it. We tell you what we hold in-house and what we would bring a specialist partner in to support, before the work begins rather than after a problem appears.
We do not win on a list of names or a wall of credentials. We win on getting the structure right before the clock starts, and on telling you the truth about where you stand at every stage after it does.
That is the whole of it. Senior people who scope your registration and see it through, Thai and Western working the regulation and the relationships together, and straight answers from the first conversation, including when the answer is no.